Algen Biotechnologies
YC W20 · Active · Using CRISPR to find treatments for cancer and inflammation
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
| Other | Active | YCW23 | |
| AI | Active | YCS19 | |
| Other | Active | YCS19 | |
| Other | Active | YCW22 | |
| Other | Active | YCW21 |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
| Other | Public | YCS20 | |
| AI | Active | YCW15 | |
| AI | Active | YCS21 | |
| ShasqiShared: therapeutics, biotech, cancerActiveAI | AI | Active | YCW15 |
| AI | Active | YCW20 |
Also from W20 in AI
All of W20About Algen Biotechnologies
Algen is using CRISPR to uncover disease-driving RNA messages to find treatments for cancer, inflammation and diseases with high unmet needs. We are harnessing the power of CRISPR and machine learning to find first-in-class drugs that modulate RNA messages at single-cell resolution. Algen's founders are bioengineer from Jennifer Doudna Lab and biotech commercialization expert, teamed up with experienced pharmaceutical executives.
- YC batch
- W20 · Winter 2020
- Status, per YC
- Active
- Category
- AI
- Team size
- 15
- Location
- San Francisco, CA, USA
- Checked
- 1h ago
YC tags: CRISPR, Biotech, Therapeutics, Drug discovery, AI
Algen Biotechnologies: questions
Which YC batch was Algen Biotechnologies in?
Algen Biotechnologies was in Y Combinator's Winter 2020 batch (W20).
Is Algen Biotechnologies still active?
Y Combinator lists Algen Biotechnologies as active.
Where is Algen Biotechnologies based?
Algen Biotechnologies lists San Francisco, CA, USA as its location on YC's directory.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.